Global Organ Transplant Rejection Medication Market Research Report 2023

The global Organ Transplant Rejection Medication market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Organ Transplant Rejection Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Organ Transplant Rejection Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Organ Transplant Rejection Medication in Kidney Transplant is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Organ Transplant Rejection Medication include GlaxoSmithKline, Novartis, F. Hoffmann-La Roche, Astellas Pharma, Pfizer, AbbVie, Allergan, Bristol-Myers Squibb Company (BMS) and Sanofi, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Organ Transplant Rejection Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Rejection Medication.

The Organ Transplant Rejection Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Organ Transplant Rejection Medication market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Organ Transplant Rejection Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Organ Transplant Rejection Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Calcineurin Inhibitors

1.2.3 Antiproliferative Agents

1.2.4 mTOR Inhibitors

1.2.5 Antibodies

1.2.6 Steroids

1.3 Market by Application

1.3.1 Global Organ Transplant Rejection Medication Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Kidney Transplant

1.3.3 Bone Marrow Transplant

1.3.4 Liver Transplant

1.3.5 Heart Transplant

1.3.6 Lung Transplant

1.3.7 Other Transplants

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Organ Transplant Rejection Medication Market Perspective (2018-2029)

2.2 Organ Transplant Rejection Medication Growth Trends by Region

2.2.1 Global Organ Transplant Rejection Medication Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Organ Transplant Rejection Medication Historic Market Size by Region (2018-2023)

2.2.3 Organ Transplant Rejection Medication Forecasted Market Size by Region (2024-2029)

2.3 Organ Transplant Rejection Medication Market Dynamics

2.3.1 Organ Transplant Rejection Medication Industry Trends

2.3.2 Organ Transplant Rejection Medication Market Drivers

2.3.3 Organ Transplant Rejection Medication Market Challenges

2.3.4 Organ Transplant Rejection Medication Market Restraints

3.1 Global Top Organ Transplant Rejection Medication Players by Revenue

3.1.1 Global Top Organ Transplant Rejection Medication Players by Revenue (2018-2023)

3.1.2 Global Organ Transplant Rejection Medication Revenue Market Share by Players (2018-2023)

3.2 Global Organ Transplant Rejection Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Organ Transplant Rejection Medication Revenue

3.4 Global Organ Transplant Rejection Medication Market Concentration Ratio

3.4.1 Global Organ Transplant Rejection Medication Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Organ Transplant Rejection Medication Revenue in 2022

3.5 Organ Transplant Rejection Medication Key Players Head office and Area Served

3.6 Key Players Organ Transplant Rejection Medication Product Solution and Service

3.7 Date of Enter into Organ Transplant Rejection Medication Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Organ Transplant Rejection Medication Historic Market Size by Type (2018-2023)

4.2 Global Organ Transplant Rejection Medication Forecasted Market Size by Type (2024-2029)

5.1 Global Organ Transplant Rejection Medication Historic Market Size by Application (2018-2023)

5.2 Global Organ Transplant Rejection Medication Forecasted Market Size by Application (2024-2029)

6.1 North America Organ Transplant Rejection Medication Market Size (2018-2029)

6.2 North America Organ Transplant Rejection Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Organ Transplant Rejection Medication Market Size by Country (2018-2023)

6.4 North America Organ Transplant Rejection Medication Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Organ Transplant Rejection Medication Market Size (2018-2029)

7.2 Europe Organ Transplant Rejection Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Organ Transplant Rejection Medication Market Size by Country (2018-2023)

7.4 Europe Organ Transplant Rejection Medication Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Organ Transplant Rejection Medication Market Size (2018-2029)

8.2 Asia-Pacific Organ Transplant Rejection Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Organ Transplant Rejection Medication Market Size by Region (2018-2023)

8.4 Asia-Pacific Organ Transplant Rejection Medication Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Organ Transplant Rejection Medication Market Size (2018-2029)

9.2 Latin America Organ Transplant Rejection Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Organ Transplant Rejection Medication Market Size by Country (2018-2023)

9.4 Latin America Organ Transplant Rejection Medication Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Organ Transplant Rejection Medication Market Size (2018-2029)

10.2 Middle East & Africa Organ Transplant Rejection Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Organ Transplant Rejection Medication Market Size by Country (2018-2023)

10.4 Middle East & Africa Organ Transplant Rejection Medication Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Organ Transplant Rejection Medication Introduction

11.1.4 GlaxoSmithKline Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.1.5 GlaxoSmithKline Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Organ Transplant Rejection Medication Introduction

11.2.4 Novartis Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 F. Hoffmann-La Roche

11.3.1 F. Hoffmann-La Roche Company Detail

11.3.2 F. Hoffmann-La Roche Business Overview

11.3.3 F. Hoffmann-La Roche Organ Transplant Rejection Medication Introduction

11.3.4 F. Hoffmann-La Roche Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.3.5 F. Hoffmann-La Roche Recent Development

11.4 Astellas Pharma

11.4.1 Astellas Pharma Company Detail

11.4.2 Astellas Pharma Business Overview

11.4.3 Astellas Pharma Organ Transplant Rejection Medication Introduction

11.4.4 Astellas Pharma Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.4.5 Astellas Pharma Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Detail

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Organ Transplant Rejection Medication Introduction

11.5.4 Pfizer Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.5.5 Pfizer Recent Development

11.6 AbbVie

11.6.1 AbbVie Company Detail

11.6.2 AbbVie Business Overview

11.6.3 AbbVie Organ Transplant Rejection Medication Introduction

11.6.4 AbbVie Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.6.5 AbbVie Recent Development

11.7 Allergan

11.7.1 Allergan Company Detail

11.7.2 Allergan Business Overview

11.7.3 Allergan Organ Transplant Rejection Medication Introduction

11.7.4 Allergan Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.7.5 Allergan Recent Development

11.8 Bristol-Myers Squibb Company (BMS)

11.8.1 Bristol-Myers Squibb Company (BMS) Company Detail

11.8.2 Bristol-Myers Squibb Company (BMS) Business Overview

11.8.3 Bristol-Myers Squibb Company (BMS) Organ Transplant Rejection Medication Introduction

11.8.4 Bristol-Myers Squibb Company (BMS) Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.8.5 Bristol-Myers Squibb Company (BMS) Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Organ Transplant Rejection Medication Introduction

11.9.4 Sanofi Revenue in Organ Transplant Rejection Medication Business (2018-2023)

11.9.5 Sanofi Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Organ Transplant Rejection Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Calcineurin Inhibitors

    Table 3. Key Players of Antiproliferative Agents

    Table 4. Key Players of mTOR Inhibitors

    Table 5. Key Players of Antibodies

    Table 6. Key Players of Steroids

    Table 7. Global Organ Transplant Rejection Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Organ Transplant Rejection Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Organ Transplant Rejection Medication Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Organ Transplant Rejection Medication Market Share by Region (2018-2023)

    Table 11. Global Organ Transplant Rejection Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Organ Transplant Rejection Medication Market Share by Region (2024-2029)

    Table 13. Organ Transplant Rejection Medication Market Trends

    Table 14. Organ Transplant Rejection Medication Market Drivers

    Table 15. Organ Transplant Rejection Medication Market Challenges

    Table 16. Organ Transplant Rejection Medication Market Restraints

    Table 17. Global Organ Transplant Rejection Medication Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Organ Transplant Rejection Medication Market Share by Players (2018-2023)

    Table 19. Global Top Organ Transplant Rejection Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Rejection Medication as of 2022)

    Table 20. Ranking of Global Top Organ Transplant Rejection Medication Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Organ Transplant Rejection Medication Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Organ Transplant Rejection Medication Product Solution and Service

    Table 24. Date of Enter into Organ Transplant Rejection Medication Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Organ Transplant Rejection Medication Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Organ Transplant Rejection Medication Revenue Market Share by Type (2018-2023)

    Table 28. Global Organ Transplant Rejection Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Organ Transplant Rejection Medication Revenue Market Share by Type (2024-2029)

    Table 30. Global Organ Transplant Rejection Medication Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Organ Transplant Rejection Medication Revenue Market Share by Application (2018-2023)

    Table 32. Global Organ Transplant Rejection Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Organ Transplant Rejection Medication Revenue Market Share by Application (2024-2029)

    Table 34. North America Organ Transplant Rejection Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Organ Transplant Rejection Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Organ Transplant Rejection Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Organ Transplant Rejection Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Organ Transplant Rejection Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Organ Transplant Rejection Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Organ Transplant Rejection Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Organ Transplant Rejection Medication Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Organ Transplant Rejection Medication Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Organ Transplant Rejection Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Organ Transplant Rejection Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Organ Transplant Rejection Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Organ Transplant Rejection Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Organ Transplant Rejection Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Organ Transplant Rejection Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 49. GlaxoSmithKline Company Detail

    Table 50. GlaxoSmithKline Business Overview

    Table 51. GlaxoSmithKline Organ Transplant Rejection Medication Product

    Table 52. GlaxoSmithKline Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 53. GlaxoSmithKline Recent Development

    Table 54. Novartis Company Detail

    Table 55. Novartis Business Overview

    Table 56. Novartis Organ Transplant Rejection Medication Product

    Table 57. Novartis Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 58. Novartis Recent Development

    Table 59. F. Hoffmann-La Roche Company Detail

    Table 60. F. Hoffmann-La Roche Business Overview

    Table 61. F. Hoffmann-La Roche Organ Transplant Rejection Medication Product

    Table 62. F. Hoffmann-La Roche Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 63. F. Hoffmann-La Roche Recent Development

    Table 64. Astellas Pharma Company Detail

    Table 65. Astellas Pharma Business Overview

    Table 66. Astellas Pharma Organ Transplant Rejection Medication Product

    Table 67. Astellas Pharma Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 68. Astellas Pharma Recent Development

    Table 69. Pfizer Company Detail

    Table 70. Pfizer Business Overview

    Table 71. Pfizer Organ Transplant Rejection Medication Product

    Table 72. Pfizer Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 73. Pfizer Recent Development

    Table 74. AbbVie Company Detail

    Table 75. AbbVie Business Overview

    Table 76. AbbVie Organ Transplant Rejection Medication Product

    Table 77. AbbVie Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 78. AbbVie Recent Development

    Table 79. Allergan Company Detail

    Table 80. Allergan Business Overview

    Table 81. Allergan Organ Transplant Rejection Medication Product

    Table 82. Allergan Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 83. Allergan Recent Development

    Table 84. Bristol-Myers Squibb Company (BMS) Company Detail

    Table 85. Bristol-Myers Squibb Company (BMS) Business Overview

    Table 86. Bristol-Myers Squibb Company (BMS) Organ Transplant Rejection Medication Product

    Table 87. Bristol-Myers Squibb Company (BMS) Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 88. Bristol-Myers Squibb Company (BMS) Recent Development

    Table 89. Sanofi Company Detail

    Table 90. Sanofi Business Overview

    Table 91. Sanofi Organ Transplant Rejection Medication Product

    Table 92. Sanofi Revenue in Organ Transplant Rejection Medication Business (2018-2023) & (US$ Million)

    Table 93. Sanofi Recent Development

    Table 94. Research Programs/Design for This Report

    Table 95. Key Data Information from Secondary Sources

    Table 96. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Organ Transplant Rejection Medication Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Organ Transplant Rejection Medication Market Share by Type: 2022 VS 2029

    Figure 3. Calcineurin Inhibitors Features

    Figure 4. Antiproliferative Agents Features

    Figure 5. mTOR Inhibitors Features

    Figure 6. Antibodies Features

    Figure 7. Steroids Features

    Figure 8. Global Organ Transplant Rejection Medication Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Organ Transplant Rejection Medication Market Share by Application: 2022 VS 2029

    Figure 10. Kidney Transplant Case Studies

    Figure 11. Bone Marrow Transplant Case Studies

    Figure 12. Liver Transplant Case Studies

    Figure 13. Heart Transplant Case Studies

    Figure 14. Lung Transplant Case Studies

    Figure 15. Other Transplants Case Studies

    Figure 16. Organ Transplant Rejection Medication Report Years Considered

    Figure 17. Global Organ Transplant Rejection Medication Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 18. Global Organ Transplant Rejection Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 19. Global Organ Transplant Rejection Medication Market Share by Region: 2022 VS 2029

    Figure 20. Global Organ Transplant Rejection Medication Market Share by Players in 2022

    Figure 21. Global Top Organ Transplant Rejection Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Rejection Medication as of 2022)

    Figure 22. The Top 10 and 5 Players Market Share by Organ Transplant Rejection Medication Revenue in 2022

    Figure 23. North America Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. North America Organ Transplant Rejection Medication Market Share by Country (2018-2029)

    Figure 25. United States Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Canada Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Europe Organ Transplant Rejection Medication Market Share by Country (2018-2029)

    Figure 29. Germany Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. France Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. U.K. Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Italy Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Russia Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Nordic Countries Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Asia-Pacific Organ Transplant Rejection Medication Market Share by Region (2018-2029)

    Figure 37. China Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Japan Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. South Korea Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Southeast Asia Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. India Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Australia Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Latin America Organ Transplant Rejection Medication Market Share by Country (2018-2029)

    Figure 45. Mexico Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Brazil Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Organ Transplant Rejection Medication Market Share by Country (2018-2029)

    Figure 49. Turkey Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia Organ Transplant Rejection Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. GlaxoSmithKline Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 52. Novartis Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 54. Astellas Pharma Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 55. Pfizer Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 56. AbbVie Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 57. Allergan Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 58. Bristol-Myers Squibb Company (BMS) Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 59. Sanofi Revenue Growth Rate in Organ Transplant Rejection Medication Business (2018-2023)

    Figure 60. Bottom-up and Top-down Approaches for This Report

    Figure 61. Data Triangulation

    Figure 62. Key Executives Interviewed